Abstract:Numerous studies have proved that cell-nonautonomous regulation of neoplastic cells is a distinctive and essential characteristic of tumorigenesis. Two way communications between the tumor and the stroma, or within the tumor significantly influence disease progression and modify treatment responses. In the tumor microenvironment (TME), malignant cells utilize paracrine signaling initiated by adjacent stromal cells to acquire resistance against multiple types of anticancer therapies, wherein extracellular vesicles (EVs) substantially promote such events. EVs are nanoscaled particles enclosed by phospholipid bilayers, and can mediate intercellular communications between cancerous cells and the adjacent microenvironment to accelerate pathological proceeding. Here we review the most recent studies of EV biology and focus on key cell lineages of the TME and their EV cargoes that are biologically active and responsible for cancer resistance, including proteins, RNAs, and other potentially essential components. Since EVs are emerging as novel but critical elements in establishing and maintaining hallmarks of human cancer, timely and insightful understanding of their molecular properties and functional mechanisms would pave the road for clinical diagnosis, prognosis, and effective targeting in the global landscape of precision medicine. Further, we address the potential of EVs as promising biomarkers in cancer clinics and summarize the technical improvements in EV preparation, analysis, and imaging. We highlight the practical issues that should be exercised with caution to guide the development of targeting agents and therapeutic methodologies to minimize cancer resistance driven by EVs, thereby allowing to effectively control the early steps of disease exacerbation.

Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics

The role of extracellular vesicle immune checkpoints in cancer

Tumor Immune Checkpoints and Their Associated Inhibitors

Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

Extracellular vesicles and the regulation of tumor immunity: Current progress and future directions

Extracellular vesicles derived from immune cells: Role in tumor therapy

Extracellular vesicles in the tumor immune microenvironment

Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects

Extracellular vesicle-based checkpoint regulation and immune state in cancer

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Extracellular Vesicles-Based Drug Delivery Systems for Cancer Immunotherapy

Tumor-derived Extracellular Vesicles: Regulators of Tumor Microenvironment and the Enlightenment in Tumor Therapy

Extracellular vesicle-mediated communication between CD8+ cytotoxic T cells and tumor cells

The function and clinical application of extracellular vesicles in innate immune regulation

Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy

Extracellular vesicles in immunomodulation and tumor progression

Extracellular vesicle-mediated crosstalk in tumor microenvironment dominates tumor fate

Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy

Engineered extracellular vesicles and their mimetics for cancer immunotherapy

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies